Zdravlje is pleased to announce that as of 1st August 2022, Mr. Milan Markicevic has joined our senior management team as Group Finance Director, directly reporting to Kiren Naidoo (CEO).
Milan holds a master’s degree at the Faculty of Economics of the University of Belgrade, strategic financial management module and has the ACCA certificate since 2019. In 2017, he completed Leadership program at the London School of Business.
Milan was most recently Plant Finance Director in Russia, at the company “JT International”. He spent 4 years in that position and prior to that he was leading controlling team within finance department and was team member at projects of merger and upgrade of the SAP system (finance modul).
We are confident that the experiences gained at these positions and companies will support Zdravlje’s further expansion locally and internationally.
Commenting on his joining Zdravlje Team, Milan shared his enthusiasm: “I am very pleased to be joining Zdravlje, the company with such long tradition and high standards in pharmaceuticals. I am looking forward to working with the team and do my best to contribute to the further growth and achievement of the Company goals.”
“I am delighted to welcome Milan to our team. We are confident that his mix of industrial, commercial and strategic expertise (gained in Serbia and abroad) will create substantial value for us, particularly as we prepare for our next phase of international growth.” said Kiren Naidoo, CEO of Zdravlje.
We welcome Milan to the team and wish him all the best in his new role at Zdravlje.